Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
How to sound like an astronaut as you follow the first human moon mission in more than half a century - 2Vote in favor of the bloom plan that adds a bit of excellence to your life!
- 3Travel Through France's Most Iconic Wine Regions By Train On An Immersive Seven-Day Journey
- 4Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character.
- 5The biggest black hole breakthroughs of 2025
- The Rhythms of the Street: Shipping's Tune in the Economy's Symphony
- Book excerpt: "Eat Your Ice Cream" by Ezekiel J. Emanuel, M.D.
- Artemis II crew cleared to depart Earth orbit, head for moon
- 6 Web-based Staple Help You Can Trust
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- RFK Jr.'s handpicked vaccine panel just voted to stop recommending hepatitis B shots for all newborns. Why experts object.
- Toyota Just Electrified a Pickup Legend, but It Won’t Be Cheap
- Lawsuit claims ChatGPT exacerbated man's delusions leading to murder-suicide
- The race to mine the moon is on – and it urgently needs some clear international rules
